![1]()
News
In-hospital flu shot reduced readmissions in pneumonia patients
October 22, 2019
NEW ORLEANS – In-hospital influenza vaccination linked to lower readmission rates in database analysis.
![1]()
News
Guidelines updated for treating community-acquired pneumonia
October 18, 2019
The new guidelines update those from 2007 and include recommended changes in antibiotic treatment and the elimination of the category known as health care–acquired pneumonia.
News
Short-term statin use linked to risk of skin and soft tissue infections
October 11, 2019
Use of statins was associated with increased risk of SSTIs at an average of 91, 182, and 365 days.
![1]()
News
Influenza vaccination modestly reduces risk of hospitalizations in patients with COPD
October 9, 2019
Older patients with COPD need more effective influenza vaccines and other preventive strategies.
![1]()
Opinion
IDWeek examined hot topics in the clinical treatment of infectious diseases
October 6, 2019
WASHINGTON – Identifying diseases using cell-free microbial DNA from plasma and next-generation DNA sequencing are some of the hot topics in ID diagnosis and treatment.
![1]()
News
Measles 2019: Most cases occurred in close-knit, undervaccinated communities
October 4, 2019
CDC researcher report on 22 outbreaks in 17 states.
![1]()
News
Epidemiology and costs of sepsis in the United States
October 2, 2019
What is the economic burden of sepsis in the U.S. health care system?
News
Lefamulin found noninferior to moxifloxacin for bacterial pneumonia
October 1, 2019
Oral lefamulin, the first pleuromutilin antibiotic approved for intravenous and oral administration, was noninferior to oral moxifloxacin for inducing an early clinical response in patients with bacterial pneumonia, acording to data from a global multicenter study of 738 individuals.
![1]()
News
Vitamin C infusion falls short for sepsis and ARDS patients
October 1, 2019
Vitamin C failed to improve organ dysfunction, inflammation, or vascular injury in adults with sepsis and ARDS.
![1]()
News
Hospital-acquired C. diff. tied to four ‘high-risk’ antibiotic classes
September 16, 2019
High-risk antibiotics included second-, third-, and fourth-generation cephalosporins, fluoroquinolones, carbapenems, and lincosamides.
